Atea Pharmaceuticals Inc (AVIR)
Cost of Revenue
$38.34M
TTM · Period ending: · USD
AVIR Cost of Revenue
Latest reported$38.34Mperiod ending
Latest reported$38.34Mperiod ending
AVIR TTM Cost of Revenue ($4.00K → $38.34M)
TTM cost of revenue
High-resolution chart · PNG
AVIR cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 38,338,000 | |
| 40,757,000 | |
| 44,093,000 | |
| 44,197,000 | |
| 25,886,000 | |
| 23,571,000 | |
| 20,235,000 | |
| 20,235,000 | |
| 18,371,000 | |
| 34,403,000 | |
| 63,253,000 | |
| 77,867,000 | |
| 59,808,000 | |
| 43,672,000 | |
| 44,351,000 | |
| 87,444,000 | |
| 130,463,000 | |
| 170,266,000 | |
| 167,204,000 | |
| 123,239,000 | |
| 93,821,000 | |
| 61,773,000 | |
| 35,206,000 | |
| 21,364,000 | |
| 7,763,000 | |
| 8,000 | |
| 4,000 |